Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
2000 ◽
Vol 83
(4)
◽
pp. 473-479
◽
Keyword(s):
2006 ◽
Vol 66
(22)
◽
pp. 10911-10918
◽
Keyword(s):
2001 ◽
Vol 91
(4)
◽
pp. 433-437
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):